Product Description

Indications: Zoventa is indicated for the treatment of mild to moderate infections caused by susceptible organisms. These include acute bacterial exacerbations of chronic bronchitis caused by Haemophilus influenzae (including β-lactamase producing strains), Moraxella catarrhalis (including β-lactamase producing strains), and penicillin-susceptible Streptococcus pneumoniae; acute bacterial otitis media caused by Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pyogenes; and pharyngitis and tonsillitis caused by Streptococcus pyogenes.

Pharmacology: Ceftibuten is a semi-synthetic, third-generation cephalosporin antibiotic intended for oral use. It exerts bactericidal action by binding to essential penicillin-binding proteins (PBPs) in bacterial cell walls, thereby inhibiting cell wall synthesis and leading to bacterial cell death.

Dosage & Administration: The dosage depends on the type and severity of infection. For otitis media, tonsillitis, and pharyngitis: adults 400 mg once daily for 10 days; children over 6 months 9 mg/kg/day (maximum 400 mg) once daily for 10 days. For bronchitis: adults 400 mg once daily for 10 days; children over 12 years 400 mg once daily for 10 days. For cystitis: adults 400 mg once daily for 7 days; children over 12 years 400 mg once daily for 7 days. For pneumonia: adults 200 mg every 12 hours for 7–14 days; children over 12 years same dosing. For sinusitis: adults 400 mg once daily for 10–14 days; children over 12 years same dosing. For urinary tract infections: adults 400 mg once daily for 10 days; children over 6 months 9 mg/kg/day (maximum 400 mg) once daily for 10 days.

Interaction: Concomitant use with theophylline or antacids does not significantly affect pharmacokinetics. Ranitidine may increase peak plasma concentration (Cmax) and overall exposure (AUC) of ceftibuten.

Contraindications: Contraindicated in patients with known hypersensitivity to ceftibuten or other cephalosporin antibiotics.

Side Effects: Common adverse effects include nausea, diarrhea, headache, dyspepsia, abdominal pain, dizziness, and vomiting.

Pregnancy & Lactation: Classified as pregnancy category B. It should be used during pregnancy only if clearly needed and when benefits outweigh risks. It is unknown whether ceftibuten is excreted in human milk; therefore, caution is advised in breastfeeding mothers.

Precautions & Warnings: Prolonged use may lead to overgrowth of resistant organisms. Use with caution in patients with a history of gastrointestinal disease, especially colitis. Dose adjustment may be required in patients with renal impairment, and careful monitoring is recommended.

Use in Special Populations: In renal impairment, dose adjustment is necessary: for creatinine clearance 5–29 mL/min, 2.25 mg/kg or 100 mg once daily; for 30–49 mL/min, 4.5 mg/kg or 200 mg once daily. No dose adjustment is required in hepatic impairment.

Therapeutic Class: Third generation cephalosporin antibiotic

Reconstitution: The suspension should be prepared by adding the provided purified water to the granules bottle, then shaking well for at least one minute. The prepared suspension should be measured using a proper measuring device and stored in a refrigerator. It should be used within 14 days and shaken well before each use.

Storage Conditions: Store below 25°C, protected from light and moisture. After reconstitution, store the suspension at 2–8°C and use within 14 days. Keep out of reach of children.